您的位置: 首页 > 农业专利 > 详情页

Treatment of fibrosis and liver diseases
专利权人:
Apeiron Biologics AG
发明人:
LOIBNER, HANS,SCHUSTER, MANFRED
申请号:
PL12192755
公开号:
PL2572724T3
申请日:
2008.12.22
申请国别(地区):
PL
年份:
2018
代理人:
摘要:
Angiotensin converting enzyme 2 protein or nucleic acid is used to treat or prevent fibrosis or liver disease. ACTIVITY : Cytostatic Hepatotropic. MECHANISM OF ACTION : Collagen production inhibitor. After bile duct ligation, mice were treated with recombinant angiotensin converting enzyme 2 protein by intravenous injection at a dose of 2 mg/kg once a day for 14 days. Collagen-producing cells were monitored by smooth muscle actin (SMA) assay. The numbers of such cells increased greatly in the damaged livers of untreated mice, whereas SMA was not detectable in the livers of the treated mice.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充